2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis

Details for Australian Patent Application No. 2004285811 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Sumida, Takumi; Tomishige, Tatsuo; Itotani, Motohiro; Hasegawa, Takeshi; Tsubouchi, Hidetsugu; Hashizume, Hiroyuki; Sasaki, Hirofumi; Matsumoto, Makoto; Tanaka, Kazuho; Miyamura, Shin; Ohguro, Kinue; Takemura, Isao; Kawasaki, Masanori; Haraguchi, Yoshikazu

Agent Davies Collison Cave

Pub. Number AU-B-2004285811

PCT Pub. Number WO2005/042542

Priority 2003-373206 31.10.03 JP; 2004-111720 06.04.04 JP

Filing date 29 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 12 June 2008

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/042542 Priority application(s): WO2005/042542

12 June 2008 Application Accepted

  Published as AU-B-2004285811

9 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285813-Vitamin D3 lactam derivative

2004285809-2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors